Broker call● Neutral for Alkem Laboratories

Alkem Labs: Hold on till growth gets a new boost

1 source · first seen 22:16 26 Sept · updated 22:16 26 Sept

The brief

Written from 1 report · check the source before you trade

CDMO and medtech segments are expected to supplement Alkem’s base-business growth over the long term
Long-term growth hinges on CDMO and medtech expansion, affecting Alkem Laboratories investors

Pick a tag to see all its stories

1 report · earliest 22:16